| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $379.8M | +23.9% |
| Cost of Revenue | $260.2M | +4.4% |
| Gross Profit | $119.6M | +108.9% |
| R&D Expense | $41.1M | -8.8% |
| SG&A Expense | $81.5M | -16.2% |
| Operating Income | -$116.1M | -8.8% |
| Interest Expense | $1.4M | -46.5% |
| Pre-tax Income | -$195.5M | -83.7% |
| Income Tax | $0 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.0M | +63.9% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $120.6M | -13.0% |
| Inventory | $143.3M | -4.3% |
| Current Assets | $428.0M | +0.6% |
| Total Assets | $951.9M | -13.2% |
| Current Liabilities | $330.2M | -18.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.8M | +103.7% |
| Capital Expenditures | $27.7M | -85.2% |
| Investing Cash Flow | -$12.2M | +92.7% |
| Financing Cash Flow | $37.6M | +13.8% |
| Free Cash Flow | -$24.9M | +90.5% |
| -100.0% |
| Net Income | -$195.5M | -83.8% |
| EPS (Basic) | -$0.61 | -79.4% |
| EPS (Diluted) | -$0.61 | -79.4% |
| Long-term Debt |
| $41.1M |
| -6.2% |
| Total Liabilities | $564.0M | +5.9% |
| Stockholders' Equity | $387.9M | -31.2% |